Elsevier Business Intelligence hosts 2009's largest medical device summit

NewsGuard 100/100 Score

Elsevier Business Intelligence, the medtech industry's leading strategic partner and investment conference organizer, hosted the year's largest annual strategic partnership and investment meeting, 'IN3 Medical Device Summit', on October 20-21 at San Francisco's InterContinental Mark Hopkins Hotel. This event followed Elsevier Business Intelligence's 'Medical Device Investor Day', also held at the InterContinental Mark Hopkins, on October 19.

IN3 Medical Device Summit, with 25 sponsors, was attended by more than 250 registered guests, including venture capitalists and medtech business-development executives who learned about the latest innovations and investment opportunities from 50 emerging medical technology companies seeking funding and/or strategic partnerships.

"This conference offered me the chance to sit down not only with a major multinational company but also several other investors whom I would not likely have met otherwise," said Allen Braswell, President and CEO of Pico-Tesla Magnetic Therapies, one of the presenting companies at the IN3 Medical Device Summit. "This is my second IN3 event, and I believe these meetings offer emerging companies a great value for getting in front of top-shelf investors."

"The IN3 Medical Device Summit proved to be a very effective venue for us to heighten awareness about our organization," added Mark B. Leahey, President and CEO of the Medical Device Manufacturers Association (MDMA), one of the sponsors of IN3 Medical Device Summit.

Upcoming IN3 events include: (1) March 3-5, 2010, IN3 WEST, Las Vegas: "Growing Your Medical Technology Business through Financing, M&A and Strategic Partnerships" (The Venetian Resort Hotel & Casino); and (2) April 29-30, 2010: IN3 EUROPE, Paris: "Bridging European and U.S. Medical Device Innovators, Investors and Companies" (Marriott Rive Gauche Hotel). For more information about these upcoming IN3 conferences, visit www.medtechinsight.com or contact Kristy Grimes at 480-985-9512, 888-290-2225 (U.S. toll-free), or email [email protected].

SOURCE: Elsevier Business Intelligence

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New tARC-seq method enhances precision in tracking SARS-CoV-2 mutations